SCHEMBL16658695

SCHEMBL16658695

CC(=O)NCCCCCCCCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.68
HPGD P15428 3/20 0.62
KMT2A Q03164 3/20 0.62
ALDH1A1 P00352 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.60
LMNA P02545 1/20 0.59
TSHR P16473 1/20 0.59
SIGMAR1 Q99720 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
POLB P06746 1/20 0.58
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
GAA P10253 1/20 0.57
KDM4E B2RXH2 1/20 0.57
MAPK1 P28482 1/20 0.57
HIF1A Q16665 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16658696 1.00 TRPV1 (0.68) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL16658698 1.00 TRPV1 (0.68) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL5462618 1.00 TRPV1 (0.68) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL16658733 1.00 TRPV1 (0.68) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL16658697 1.00 TRPV1 (0.68) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL425223 0.98 TRPV1 (0.65) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL422827 0.93 L3MBTL1 (0.68) HPGDKMT2ASMN1; SMN2L3MBTL1CYP2D6
SCHEMBL15093399 0.85 EPHX2 (0.74) TRPV1HPGDKMT2AALDH1A1LMNA
SCHEMBL2021336 0.85 TRPV1 (0.72) TRPV1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL15093824 0.85 EPHX2 (0.74) TRPV1HPGDKMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9199948-B2 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-12-01 US disclosed
US-9199948-B2 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-12-01 US disclosed
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-04-23 US disclosed
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS TRPV1, TRPA1, P2RX3 TRPV1 1/4885HPGD 607/4885KMT2A 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.